ITRMF

Iterum Therapeutics plc

Healthcare · Biotechnology

$66.16 sample

-0.76 (-1.14%) 1D

Market cap

$115.6B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-10

Alerts

8

Price$66.16 -9.94% 3M daily closessample

75.5566.16

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider buy: Chief Executive Officer
Sep 24INSInsider sell: 10% owner
Sep 15INSInsider sell: 10% owner
Sep 10SEC8-K filed: material event
Sep 07SEC10-Q filed
Sep 02SEC8-K filed: material event
Aug 25INSInsider sell: EVP, Operations
Aug 20SECForm 144 filed

Sign up to see the real ITRMF record →

Company facts

SEC EDGAR registration

Name: Iterum Therapeutics plc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -31sample, -100 to +100
Reporting currency: USD

Who is positioning in ITRMF

sample

Insiders: 30 insider transactions over 90 days, net selling, $84.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 42 funds hold $2.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.8B +21.3% y/y

Q4 2024Q3 2026

Inventory$2.7B +8.3% y/y

Q4 2024Q3 2026

Accounts receivable$2.1B +13.2% y/y

Q4 2024Q3 2026

Total debt$5.4B +10.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $60.6B +10.9% 3M
Sample peer B: $61.6B +6.6% 3M
Sample peer C: $104.0B -13.1% 3M
Sample peer D: $84.8B +11.8% 3M
Sample peer E: $74.4B +14.5% 3M